Patent · US Expired

Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases

US5059609A · kind A · utility

60Cited by
6References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 1989
Grant dateOct 22, 1991
Priority date
Expiry dateAug 4, 2009

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/582
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Substituted tetralins, chromans and related compounds which, by inhibiting 5-lipoxygenase enzyme and/or blocking leukotriene receptors, are useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction and related disease states in mammals, pharmaceutical compositions thereof, a method of treatment therewith, and to intermediates useful in the synthesis thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.